Enzo Biochem, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
HARBERT FUND ADVISORS, INC. | 02/13/2025 | 5.18 M | $3.70 M | 0.00% | 9.91% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 2.37 M | $1.69 M | -6.33% | 4.53% |
VANGUARD GROUP INC | 02/11/2025 | 1.86 M | $1.33 M | -0.94% | 3.56% |
BLACKROCK, INC. | 02/07/2025 | 959,839 | $685,613 | 0.07% | 1.84% |
02/14/2025 | 807,899 | $577,082 | 100.00% | 1.55% | |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 367,093 | $262,302 | -0.42% | 0.70% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 295,677 | $211,130 | -2.90% | 0.57% |
RBF CAPITAL, LLC | 02/14/2025 | 250,359 | $178,831 | 0.00% | 0.48% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 02/13/2025 | 187,537 | $133,958 | 60.10% | 0.36% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 177,200 | $126,574 | -1.99% | 0.34% |
STATE STREET CORP | 02/14/2025 | 168,881 | $120,632 | 9.56% | 0.32% |
LEPERCQ MULTI-ASSET FUND | 02/07/2025 | 123,000 | $87,859 | 100.00% | 0.24% |
LEPERCQ DE NEUFLIZE ASSET MANAGEMENT LLC | 02/13/2025 | 123,000 | $87,859 | 100.00% | 0.24% |
BBR PARTNERS, LLC | 02/07/2025 | 100,000 | $71,430 | 0.00% | 0.19% |
NIERENBERG INVESTMENT MANAGEMENT COMPANY, INC. | 02/13/2025 | 88,555 | $63,255 | 0.00% | 0.17% |
MORGAN STANLEY | 02/14/2025 | 67,342 | $48,102 | -6.28% | 0.13% |
NORTHERN TRUST CORP | 02/14/2025 | 67,204 | $48,004 | 0.00% | 0.13% |
SQUAREPOINT OPS LLC | 02/14/2025 | 66,221 | $47,302 | 16.90% | 0.13% |
ENGINEERS GATE MANAGER LP | 02/14/2025 | 52,281 | $37,344 | 100.00% | 0.10% |
LAZARD ASSET MANAGEMENT LLC | 02/14/2025 | 50,453 | $36,000 | 0.00% | 0.10% |
VIRTU FINANCIAL LLC | 02/11/2025 | 48,341 | $35,000 | 100.00% | 0.09% |
CITADEL ADVISORS LLC | 02/14/2025 | 45,956 | $32,826 | 72.81% | 0.09% |
PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 44,800 | $32,000 | 0.00% | 0.09% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 33,835 | $24,168 | 100.00% | 0.06% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 32,386 | $23,133 | 25.80% | 0.06% |
KEMPNER CAPITAL MANAGEMENT INC. | 01/23/2025 | 25,475 | $18,000 | 0.00% | 0.05% |
PARADIGM FINANCIAL PARTNERS, LLC | 02/13/2025 | 19,500 | $13,929 | 0.00% | 0.04% |
CITADEL ADVISORS LLC | 02/14/2025 | 18,300 | $13,072 | 695.65% | 0.04% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 17,016 | $12,155 | 100.00% | 0.03% |
HRT FINANCIAL LP | 02/14/2025 | 16,537 | $11,000 | 100.00% | 0.03% |
XTX TOPCO LTD | 02/13/2025 | 15,908 | $11,363 | -53.69% | 0.03% |
SHULMAN DEMEO ASSET MANAGEMENT LLC | 01/15/2025 | 15,487 | $11,062 | 0.00% | 0.03% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 14,955 | $10,682 | 0.00% | 0.03% |
TLS ADVISORS LLC | 02/13/2025 | 13,616 | $10,000 | 0.00% | 0.03% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 12,913 | $9,220 | 434.92% | 0.02% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 2,215 | $1,581 | 0.09% | 0.00% |
BFSG, LLC | 01/31/2025 | 2,000 | $1,429 | -28.90% | 0.00% |
JPMORGAN CHASE & CO | 02/12/2025 | 1,923 | $1,373 | 4.91% | 0.00% |
ROYAL BANK OF CANADA | 02/14/2025 | 1,000 | $1,000 | 0.00% | 0.00% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 793 | $567 | 37.20% | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 02/07/2025 | 700 | $500 | 100.00% | 0.00% |
FMR LLC | 02/13/2025 | 555 | $396 | 29.37% | 0.00% |
UBS GROUP AG | 02/14/2025 | 278 | $198 | 0.00% | 0.00% |
SOUND INCOME STRATEGIES, LLC | 01/21/2025 | 10 | $7 | 0.00% | 0.00% |
BNP PARIBAS | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 0 | $0 | -100.00% | 0.00% |
SIMPLEX TRADING, LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
FNY INVESTMENT ADVISERS, LLC | 01/13/2025 | 0 | $0 | -100.00% | 0.00% |
SNOWDEN CAPITAL ADVISORS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Enzo Biochem, Inc. institutional Ownership - FAQ's
During the previous two years, 80 institutional investors and hedge funds held shares of Enzo Biochem, Inc.. The most heavily invested institutionals were:
BFSG, LLC: 0
HARBERT FUND ADVISORS, INC.: 5.18 M
RENAISSANCE TECHNOLOGIES LLC: 2.37 M
VANGUARD GROUP INC: 1.86 M
BlackRock, Inc.: 959,839
GEODE CAPITAL MANAGEMENT, LLC: 367,093
26.26% of Enzo Biochem, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 21.20 M shares in the last 24 months. This purchase volume represents approximately $6.57 M in transactions.